Despite a 28-fold increase in plasma EPO, anemic mice showed elevated glycemia and glucose intolerance, which ruled out glucose lowering action of EPO while corroborating a strong inverse association of blood glucose with the concurrent hematocrit (Fig. 4, E and F). The gene discussed is EPO; the disease is Glucose intolerance.